Deferoxamine, allopurinol and oxypurinol are not neuroprotective after oxygen/glucose deprivation in an organotypic hippocampal model, lacking functional endothelial cells

Brain Research

Volumn 963, Issue 1-2, 2003, Pages 72-80

  Peeters, Cacha ^a   Hoelen, Dianne ^b   Groenendaal, Floris ^a   Van Bel, Frank ^a   Bär, Dop ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Allopurinol; Deferoxamine; Hippocampus; Oxygen glucose deprivation; Reactive oxygen species

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALLOPURINOL; DEFEROXAMINE; DIZOCILPINE; GLUCOSE; IRON; N TERT BUTYL ALPHA PHENYLNITRONE; OXIPURINOL; OXYGEN; PROPIDIUM IODIDE; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL DAMAGE; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIA CELL; HIPPOCAMPUS; IRON CHELATION; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ALLOPURINOL; ANIMALS; ANTIOXIDANTS; CELL DEATH; DEFEROXAMINE; ENDOTHELIUM; EXCITATORY AMINO ACID ANTAGONISTS; FLUORESCENT DYES; GLUCOSE; HIPPOCAMPUS; HYPOXIA, BRAIN; MICROSCOPY, FLUORESCENCE; MODELS, NEUROLOGICAL; NEUROPROTECTIVE AGENTS; ORGAN CULTURE TECHNIQUES; OXYPURINOL; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS;

EID: 0242516081     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03843-X     Document Type: Article

References (46)

1. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
2. Beetsch J.W., Park T.S., Dugan L.L., Shah A.R., Gidday J.M. Xanthine oxidase-derived superoxide causes reoxygenation injury of ischemic cerebral endothelial cells. Brain Res. 786:1998;89-95.
3. Betz A.L. Identification of hypoxanthine transport and xanthine oxidase activity in brain capillaries. J. Neurochem. 44:1985;574-579.
4. Cable H., Lloyd J.B. Cellular uptake and release of two contrasting iron chelators. J. Pharm. Pharmacol. 51:1999;131-134.
5. Clemens J.A., Stephenson D.T., Smalstig E.B., Dixon E.P., Little S.P. Global ischemia activates nuclear factor-kappa B in forebrain neurons of rats. Stroke. 28:1997;1073-1080.
6. Fellman V., Raivio K.O. Reperfusion injury as the mechanism of brain damage after perinatal asphyxia. Pediatr. Res. 41:1997;599-606.
7. Gahwiler B.H. Morphological differentiation of nerve cells in thin organotypic cultures derived from rat hippocampus and cerebellum. Proc. R. Soc. Lond. B Biol. Sci. 211:1981;287-290.
8. Gaillard P.J., Voorwinden L.H., Nielsen J.L., et al. Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelial cells and astrocytes. Eur. J. Pharm. Sci. 12:2001;215-222.
9. Goldberg M.P., Weiss J.H., Pham P.C., Choi D.W. N-methyl-D-aspartate receptors mediate hypoxic neuronal injury in cortical culture. J. Pharmacol. Exp. Ther. 243:1987;784-791.
10. Hagberg H., Gilland E., Diemer N.H., Andine P. Hypoxia-ischemia in the neonatal rat brain: histopathology after post-treatment with NMDA and non-NMDA receptor antagonists. Biol. Neonate. 66:1994;205-213.
11. Halliwell B. Protection against tissue damage in vivo by desferrioxamine: what is its mechanism of action? Free Radic. Biol. Med. 7:1989;645-651.
12. S.E.G. Hamrick, A. Madan, D.M. Ferriero, Deferoxamine is neuroprotective to neonatal primary hippocampal cell cultures exposed to oxygen and glucose deprivation, Pediatr. Res. 49 (2001) A.
13. Hattori H., Morin A.M., Schwartz P.H., Fujikawa D.G., Wasterlain C.G. Posthypoxic treatment with MK-801 reduces hypoxic-ischemic damage in the neonatal rat. Neurology. 39:1989;713-718.
14. Ho E., Chen G., Bray T.M. Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes. Free Radic. Biol. Med. 28:2001;604-614.
15. Horakova L., Stolc S., Chromikova Z., Pekarova A., Derkova L. Mechanisms of hippocampal reoxygenation injury. Mol. Chem. Neuropathol. 33:1998;223-236.
16. Hudome S., Palmer C., Roberts R.L., Mauger D., Housman C., Towfighi J. The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat. Pediatr. Res. 41:1997;607-616.
17. Hurn P.D., Koehler R.C., Blizzard K.K., Traystman R.J. Deferoxamine reduces early metabolic failure associated with severe cerebral ischemic acidosis in dogs. Stroke. 26:1995;688-694.
18. Ishikawa Y., Satoh T., Enokido Y., Nishio C., Ikeuchi T., Hatanaka H. Generation of reactive oxygen species, release of L-glutamate and activation of caspases are required for oxygen-induced apoptosis of embryonic hippocampal neurons in culture. Brain Res. 824:1999;71-80.
19. Kayyali U.S., Donaldson C., Huang H., Abdelnour R., Hassoun P.M. Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia. J. Biol. Chem. 276:2001;14359-14365.
20. Ko K.M., Godin D.V. Inhibition of transition metal ion-catalysed ascorbate oxidation and lipid peroxidation by allopurinol and oxypurinol. Biochem. Pharmacol. 40:1990;803-809.
21. Laake J.H., Haug F.M., Wieloch T., Ottersen O.P. A simple in vitro model of ischemia based on hippocampal slice cultures and propidium iodide fluorescence. Brain Res. Brain Res. Protoc. 4:1999;173-184.
22. Liniger R., Popovic R., Sullivan B., Gregory G., Bickler P.E. Effects of neuroprotective cocktails on hippocampal neuron death in an in vitro model of cerebral ischemia. J. Neurosurg. Anesthesiol. 13:2001;19-25.
23. Macklis J.D., Madison R.D. Progressive incorporation of propidium iodide in cultured mouse neurons correlates with declining electrophysiological status: a fluorescence scale of membrane integrity. J. Neurosci. Methods. 31:1990;43-46.
24. Maulik D., Zanelli S., Numagami Y., Ohnishi S.T., Mishra O.P., Delivoria-Papadopoulos M. Oxygen free radical generation during in-utero hypoxia in the fetal guinea pig brain: the effects of maturity and of magnesium sulfate administration. Brain Res. 817:1999;117-122.
25. Mink R.B., Dutka A.J., Hallenbeck J.M. Allopurinol pretreatment improves evoked response recovery following global cerebral ischemia in dogs. Stroke. 22:1991;660-665.
26. Moorhouse P.C., Grootveld M., Halliwell B., Quinlan J.G., Gutteridge J.M. Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Lett. 213:1987;23-28.
27. Newell D.W., Barth A., Papermaster V., Malouf A.T. Glutamate and non-glutamate receptor mediated toxicity caused by oxygen and glucose deprivation in organotypic hippocampal cultures. J. Neurosci. 15:1995;7702-7711.
28. Palmer C., Towfighi J., Roberts R.L., Heitjan D.F. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatr. Res. 33:1993;405-411.
29. Palmer C., Roberts R.L., Bero C. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke. 25:1994;1039-1045.
30. Peterson D.A., Kelly B., Gerrard J.M. Allopurinol can act as an electron transfer agent. Is this relevant during reperfusion injury? Biochem Biophys Res Commun. 137:1986;76-79.
31. Phillis J.W., Estevez A.Y., O'Regan M.H. Protective effects of the free radical scavengers, dimethyl sulfoxide and ethanol, in cerebral ischemia in gerbils. Neurosci. Lett. 244:1998;109-111.
32. Pringle A.K., Iannotti F., Wilde G.J., Chad J.E., Seeley P.J., Sundstrom L.E. Neuroprotection by both NMDA and non-NMDA receptor antagonists in in vitro ischemia. Brain Res. 755:1997;36-46.
33. Rademakers R.P., van der Knaap M.S., Verbeeten B. Jr., Barth P.G., Valk J. Central cortico-subcortical involvement: a distinct pattern of brain damage caused by perinatal and postnatal asphyxia in term infants. J. Comput. Assist. Tomogr. 19:1995;256-263.
34. Sen S., Phillis J.W. alpha-Phenyl-tert-butyl-nitrone (PBN) attenuates hydroxyl radical production during ischemia-reperfusion injury of rat brain: an EPR study. Free Radic. Res. Commun. 19:1993;255-265.
35. Shadid M., Buonocore G., Groenendaal F., et al. Effect of deferoxamine and allopurinol on non-protein-bound iron concentrations in plasma and cortical brain tissue of newborn lambs following hypoxia-ischemia. Neurosci. Lett. 248:1998;5-8.
36. Shadid M., Moison R., Steendijk P., Hiltermann L., Berger H.M., Van Bel F. The effect of antioxidative combination therapy on post hypoxic-ischemic perfusion, metabolism, and electrical activity of the newborn brain. Pediatr. Res. 44:1998;119-124.
37. Soloniuk D.S., Perkins E., Wilson J.R. Use of allopurinol and deferoxamine in cellular protection during ischemia. Surg. Neurol. 38:1992;110-113.
38. Stoppini L., Buchs P.A., Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods. 37:1991;173-182.
39. Taylor M.D., Mellert T.K., Parmentier J.L., Eddy L.J. Pharmacological protection of reoxygenation damage to in vitro brain slice tissue. Brain Res. 347:1985;268-273.
40. Van Bel F., Shadid M., Moison R.M., et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics. 101:1998;185-193.
41. Varani J., Dame M.K., Diaz M., Stoolman L. Deferoxamine interferes with adhesive functions of activated human neutrophils. Shock. 5:1996;395-401.
42. Vlkolinsky R., Stolc S. Effects of stobadine, melatonin, and other antioxidants on hypoxia/reoxygenation-induced synaptic transmission failure in rat hippocampal slices. Brain Res. 850:1999;118-126.
43. Volpe J.J. Perinatal brain injury: from pathogenesis to neuroprotection. Ment. Retard. Dev. Disabil. Res. Rev. 7:2001;56-64.
44. Watkins M.T., al Badawi H., Cardenas R., Dubois E., Larson D.M. Endogenous reactive oxygen metabolites mediate sublethal endothelial cell dysfunction during reoxygenation. J. Vasc. Surg. 23:1996;95-103.
45. Wu S., Tamaki N., Nagashima T., Yamaguchi M. Reactive oxygen species in reoxygenation injury of rat brain capillary endothelial cells. Neurosurgery. 43:1998;577-583.
46. Ying W., Han S.K., Miller J.W., Swanson R.A. Acidosis potentiates oxidative neuronal death by multiple mechanisms. J. Neurochem. 73:1999;1549-1556.